Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00378989
Other study ID # EVA2XRCT
Secondary ID
Status Completed
Phase N/A
First received September 19, 2006
Last updated February 9, 2015
Start date September 2004
Est. completion date October 2006

Study information

Verified date February 2015
Source Evalua International
Contact n/a
Is FDA regulated No
Health authority Finland: Ethics Committee
Study type Interventional

Clinical Trial Summary

Study hypotheses were 1) Classification of the risk of sickness absence can be made with questionnaires addressing self-rated health problems; 2) Occupational health intervention of the employees at `High Risk´ of sickness absence is more effective than usual care in controlling sickness absence; 3) Health advice intervention of the employees at `Increased Risk´ of sickness absence is more effective than usual care in controlling sickness absence; 4) The interventions are cost-effective use of resources from the societal perspective.


Description:

The study design is a longitudinal cohort study with two embedded randomised trials. The risk of sickness absence is classified on the basis of self-administered questionnaires, on the basis of a priori defined cut-off limits. Two randomised trials are performed in the subgroups of `High Risk´ and `Increased Risk´ of sickness absence. The study is performed within one corporation in Finland. All employees with permanent job and age between 18 and 60 years are invited to participate.

The worker's own occupational nurses and physicians execute the occupational health program for workers at `High Risk´ for sickness absence. The employees in the "High Risk" intervention group receive a personal feedback of their health survey results in a letter, in which they are also invited to a consultation at the OHS. The main purpose of the consultation, during which the individual findings of the health survey are available for the OHS professionals, is the construction of an action plan, and if appropriate, referral to a medical specialist, or psychologist. The employees in the `High Risk´ control group receive care as usual.

The intervention for workers at `Increased Risk´ for sickness absence is executed as medical counselling over the telephone. The employees in the `Increased Risk´ intervention group receive a personal feedback of their questionnaire results in a letter, in which they were also invited to call the phone advice centre in order to receive medical advice. The employees in the `Increased Risk´ control group receive care as usual.

Sickness absence data is obtained from the employer's records, the baseline covering the one-year period before the intervention and the follow-up covering the one-year period after the intervention. Sickness absences are obtained without medical diagnoses. The study participants also fill in a health questionnaire including, among other questions, healthcare utilization variables at the one-year follow-up.

We will carry out an intention to treat analysis. We will use analysis of covariance (ANCOVA) to analyse sickness absence outcomes at 12 months, with corresponding baseline values and risk / treatment group as covariates. Economic evaluation will be performed alongside the randomised controlled trial within the `High Risk´ group.


Recruitment information / eligibility

Status Completed
Enrollment 418
Est. completion date October 2006
Est. primary completion date October 2005
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Permanent job

- Age 18 to 60 years

Exclusion Criteria:

- Pension granted

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Consultation at the occupational health services
Consultation at the occupational health services

Locations

Country Name City State
Finland Evalua International Ltd. Oy Espoo

Sponsors (7)

Lead Sponsor Collaborator
Evalua International Finnish Office for Health Technology Assessment, FinOHTA/Stakes, Helsinki University, Mutual Pension Insurance Company Ilmarinen, Pfizer, Sitra, the Finnish Innovation Fund, The Finnish Funding Agency for Technology and Innovation (TEKES)

Country where clinical trial is conducted

Finland, 

References & Publications (4)

Taimela S, Aronen P, Malmivaara A, Sintonen H, Tiekso J, Aro T. Effectiveness of a targeted occupational health intervention in workers with high risk of sickness absence: baseline characteristics and adherence as effect modifying factors in a randomized — View Citation

Taimela S, Justén S, Aronen P, Sintonen H, Läärä E, Malmivaara A, Tiekso J, Aro T. An occupational health intervention programme for workers at high risk for sickness absence. Cost effectiveness analysis based on a randomised controlled trial. Occup Envir — View Citation

Taimela S, Läärä E, Malmivaara A, Tiekso J, Sintonen H, Justén S, Aro T. Self-reported health problems and sickness absence in different age groups predominantly engaged in physical work. Occup Environ Med. 2007 Nov;64(11):739-46. Epub 2007 Feb 15. — View Citation

Taimela S, Malmivaara A, Justén S, Läärä E, Sintonen H, Tiekso J, Aro T. The effectiveness of two occupational health intervention programmes in reducing sickness absence among employees at risk. Two randomised controlled trials. Occup Environ Med. 2008 A — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sickness absence during the 12-month follow-up 12 months No
See also
  Status Clinical Trial Phase
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Withdrawn NCT02689817 - Monitoring Physiologic Data in the Development of Pressure Ulcers N/A
Completed NCT02826408 - Effect of Proton Pump Inhibitors on Palpitations N/A
Recruiting NCT02913365 - Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis N/A
Recruiting NCT01708668 - The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia N/A
Completed NCT00784108 - Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry. Phase 1
Completed NCT00230932 - Help Veterans Experience Less Pain Study (HELP-Vets) N/A
Recruiting NCT00173706 - Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis Phase 4
Terminated NCT01192594 - Milestones of Adjustment Post-Psychosis Phase 3
Withdrawn NCT01277276 - Study of Chemotherapy Side Effects in Cancer Patients: Non-invasive Optical Measurements of the Brain
Completed NCT04606199 - Examine the Effects of Meditation on Daily Psychological Stress Responses in Woman With a History of Child Adversity N/A
Withdrawn NCT01814293 - Comparison of Supportive Therapies for Symptom Relief From Pediatric Upper Respiratory Infections (URIs) N/A
Completed NCT01483703 - Noninvasive Optical Measurement of Critical Care Neonates
Completed NCT04260035 - The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients N/A
Completed NCT01340027 - A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder Phase 2
Completed NCT03471923 - Non-Motor Features of Cervical Dystonia (CD)
Completed NCT03544268 - Academic-Industrial Partnership for Translation of Acoustic Angiography Phase 4
Completed NCT01954199 - The Effectiveness of Neurodynamic Techniques in Patients With Nerve-Related Leg Pain N/A
Recruiting NCT01551238 - Energy Expenditure, Sleep and Macronutrients N/A
Completed NCT01715376 - Effects of Integrated Treatment by Traditional Chinese and Western Medicine in Reducing Cardiovascular Events